Mediators of vascular remodelling co-opted for sequential steps in lung metastasis (original) (raw)

• Fidler, I. J. The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited. Nature Rev. Cancer 3, 453–458 (2003)
  Article ADS CAS Google Scholar
• Hynes, R. O. Metastatic potential: generic predisposition of the primary tumor or rare, metastatic variants—or both? Cell 113, 821–823 (2003)
  Article CAS Google Scholar
• Gupta, G. P. & Massagué, J. Cancer metastasis: building a framework. Cell 127, 679–695 (2006)
  Article CAS Google Scholar
• Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747–752 (2000)
  Article ADS CAS Google Scholar
• van de Vijver, M. J. et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347, 1999–2009 (2002)
  Article CAS Google Scholar
• Chang, H. Y. et al. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol. 2, E7 (2004)
  Article Google Scholar
• Paik, S. et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351, 2817–2826 (2004)
  Article CAS Google Scholar
• Wang, Y. et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365, 671–679 (2005)
  Article CAS Google Scholar
• Bild, A. H. et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439, 353–357 (2006)
  Article ADS CAS Google Scholar
• Massagué, J. Sorting out breast-cancer gene signatures. N. Engl. J. Med. 356, 294–297 (2007)
  Article Google Scholar
• Bernards, R. & Weinberg, R. A. A progression puzzle. Nature 418, 823 (2002)
  Article ADS CAS Google Scholar
• Minn, A. J. et al. Genes that mediate breast cancer metastasis to lung. Nature 436, 518–524 (2005)
  Article ADS CAS Google Scholar
• Minn, A. J. et al. Lung metastasis genes couple breast tumor size and metastatic spread. Proc. Natl Acad. Sci. USA 104, 6740–6745 (2007)
  Article ADS CAS Google Scholar
• Cailleau, R., Young, R., Olive, M. & Reeves, W. J. Breast tumor cell lines from pleural effusions. J. Natl Cancer Inst. 53, 661–674 (1974)
  Article CAS Google Scholar
• Gupta, G. P. et al. Identifying site-specific metastasis genes and functions. Cold Spring Harb. Symp. Quant. Biol. 70, 1–10 (2005)
  Google Scholar
• Kang, Y. et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 3, 537–549 (2003)
  Article CAS Google Scholar
• Minn, A. J. et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J. Clin. Invest. 115, 44–55 (2005)
  Article CAS Google Scholar
• Wary, K. K., Thakker, G. D., Humtsoe, J. O. & Yang, J. Analysis of VEGF-responsive genes involved in the activation of endothelial cells. Mol. Cancer 2, 25 (2003)
  Article Google Scholar
• Carmeliet, P. & Jain, R. K. Angiogenesis in cancer and other diseases. Nature 407, 249–257 (2000)
  Article CAS Google Scholar
• Krysan, K. et al. Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res. 65, 6275–6281 (2005)
  Article CAS Google Scholar
• Dannenberg, A. J., Lippman, S. M., Mann, J. R., Subbaramaiah, K. & DuBois, R. N. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention. J. Clin. Oncol. 23, 254–266 (2005)
  Article CAS Google Scholar
• Howe, L. R. et al. HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res. 65, 10113–10119 (2005)
  Article CAS Google Scholar
• Pai, R. et al. Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nature Med. 8, 289–293 (2002)
  Article CAS Google Scholar
• Goldstein, N. I., Prewett, M., Zuklys, K., Rockwell, P. & Mendelsohn, J. Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model. Clin. Cancer Res. 1, 1311–1318 (1995)
  CAS PubMed Google Scholar
• Gijbels, K., Galardy, R. E. & Steinman, L. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94, 2177–2182 (1994)
  Article CAS Google Scholar
• Jacoby, R. F., Seibert, K., Cole, C. E., Kelloff, G. & Lubet, R. A. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis. Cancer Res. 60, 5040–5044 (2000)
  CAS PubMed Google Scholar
• Gately, S. & Li, W. W. Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy. Semin. Oncol. 31, 2–11 (2004)
  Article CAS Google Scholar
• Karashima, T. et al. Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice. Clin. Cancer Res. 8, 1253–1264 (2002)
  CAS PubMed Google Scholar
• Overall, C. M. & Kleifeld, O. Tumour microenvironment—opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nature Rev. Cancer 6, 227–239 (2006)
  Article CAS Google Scholar
• Gomis, R. R., Alarcon, C., Nadal, C., Van Poznak, C. & Massagué, J. C/EBPβ at the core of the TGFβ cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10, 203–214 (2006)
  Article CAS Google Scholar
• Giordano, S. H. et al. Is breast cancer survival improving? Cancer 100, 44–52 (2004)
  Article Google Scholar
• Solomayer, E. F., Diel, I. J., Meyberg, G. C., Gollan, C. & Bastert, G. Metastatic breast cancer: clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res. Treat. 59, 271–278 (2000)
  Article CAS Google Scholar
• Baselga, J. & Norton, L. Focus on breast cancer. Cancer Cell 1, 319–322 (2002)
  Article CAS Google Scholar
• Silva, J. M. et al. Second-generation shRNA libraries covering the mouse and human genomes. Nature Genet. 37, 1281–1288 (2005)
  Article CAS Google Scholar
• Luo, F. R. et al. Correlation of pharmacokinetics with the antitumor activity of Cetuximab in nude mice bearing the GEO human colon carcinoma xenograft. Cancer Chemother. Pharmacol. 56, 455–464 (2005)
  Article CAS Google Scholar
• Niederberger, E. et al. Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-κB. FASEB J. 15, 1622–1624 (2001)
  Article CAS Google Scholar
• Wild, R., Ramakrishnan, S., Sedgewick, J. & Griffioen, A. W. Quantitative assessment of angiogenesis and tumor vessel architecture by computer-assisted digital image analysis: effects of VEGF-toxin conjugate on tumor microvessel density. Microvasc. Res. 59, 368–376 (2000)
  Article CAS Google Scholar